NCT00168454View on ClinicalTrials.gov

A Research Study for Patients With Overactive Bladder

PHASE2CompletedINTERVENTIONAL
Enrollment

313

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

January 31, 2008

Study Completion Date

June 30, 2008

Conditions
Overactive BladderUrinary Incontinence
Interventions
BIOLOGICAL

botulinum toxin Type A

botulinum toxin Type A injected into detrusor on Day 1

DRUG

Placebo

Placebo (normal saline) injected into detrusor on Day 1

Trial Locations (6)

Unknown

Pittsburgh

Ghent

Victoria

Berlin

Warsaw

Sheffield

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY